According to RadNet's latest financial reports the company has a price-to-book ratio of 2.51.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.20 | -52.72% |
2021-12-31 | 4.65 | 18.8% |
2020-12-31 | 3.91 | -10.69% |
2019-12-31 | 4.38 | 76.13% |
2018-12-31 | 2.49 | -63.84% |
2017-12-31 | 6.88 | 19.47% |
2016-12-31 | 5.76 | -26.6% |
2015-12-31 | 7.84 | -83.49% |
2014-12-31 | 47.5 | 56.83% |
2013-12-31 | 30.3 | -162.17% |
2012-12-31 | -48.7 | 4167.08% |
2011-12-31 | -1.14 | -10.28% |
2010-12-31 | -1.27 | 28.64% |
2009-12-31 | -0.9894 | -31.03% |
2008-12-31 | -1.43 | -72.39% |
2007-12-31 | -5.20 | 301.45% |
2006-12-31 | -1.29 | 717.67% |
2005-12-31 | -0.1583 | -50.92% |
2004-12-31 | -0.3225 | -26.52% |
2003-12-31 | -0.4389 | 22.72% |
2002-12-31 | -0.3576 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | 2.19 | -12.80% | ๐บ๐ธ USA |
![]() LabCorp LH | 2.10 | -16.46% | ๐บ๐ธ USA |
![]() Psychemedics PMD | 2.32 | -7.90% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZ | 3.67 | 46.02% | ๐บ๐ธ USA |